CA
WVE icon

CoreCap Advisors’s Wave Life Sciences WVE Stock Holding History

CoreCap Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163 Buy
+28
New +$186 ﹤0.01% 3029
2025
Q2 		– Sell
-24
Closed -$194 – 3279
2025
Q1 		$194 Buy
+24
New +$262 ﹤0.01% 2988

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

CoreCap Advisors's WVE Position: Q2 2026 in Review

CoreCap Advisors opened a new position in Wave Life Sciences (WVE) in Q2 2026: 28 shares worth $163. The stake represents ﹤0.01% of the portfolio and ranks #3029 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in WVE as recently as Q1 2025.

CoreCap Advisors first reported a position in WVE in Q1 2025 and has held it in 2 quarters since. The position peaked at $194 in Q1 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • CoreCap Advisors held 28 shares of Wave Life Sciences worth $163 as of Q2 2026.
  • Wave Life Sciences was a new CoreCap Advisors position in Q2 2026.
  • Wave Life Sciences made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #3029 holding.
  • CoreCap Advisors first reported a position in Wave Life Sciences in Q1 2025 and has held it in 2 quarters since.
  • CoreCap Advisors's Wave Life Sciences position peaked at $194 in Q1 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.